Compare
Haoxi Health Technology Ltd vs Criteo S.A.
| Latest fiscal year | Haoxi Health Technology Ltd HAO | Criteo S.A. CRTO |
|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 |
| Revenue | $54.83M | $1.94B |
| Revenue growth (YoY) | +67.1% | +0.6% |
| Gross margin | 1.1% | 54.0% |
| Operating margin | -17.6% | 10.4% |
| Net margin | -17.4% | 7.4% |
| Net income | -$9.54M | $144.60M |
| EPS (Diluted) | -$386.40 | $2.64 |
| Operating cash flow | -$2.57M | $311.24M |
| Free cash flow | n/a | $208.50M |
| Cash & equivalents | $10.93M | $342.04M |
| Total assets | $21.57M | $2.20B |
| Total liabilities | $3.71M | $1.02B |
| Shareholders' equity | $17.86M | $1.19B |
| Return on year-end equity | -53.4% | 12.2% |
| Shares outstanding | n/a | 51.15M |
Revenue, most recent five fiscal years
| Fiscal year | Haoxi Health Technology Ltd | Criteo S.A. |
|---|---|---|
| Latest | $54.83M Ended 2026-06-30 | $1.94B Ended 2025-12-31 |
| 1 year earlier | $32.80M Ended 2025-06-30 | $1.93B Ended 2024-12-31 |
| 2 years earlier | $48.52M Ended 2024-06-30 | $1.95B Ended 2023-12-31 |
| 3 years earlier | $28.23M Ended 2023-06-30 | $2.02B Ended 2022-12-31 |
| 4 years earlier | $16.16M Ended 2022-06-30 | $2.25B Ended 2021-12-31 |